Abiopharma

News list

Buell Jennifer 🟢 acquired 305.0K shares (2 derivative) of AGENUS INC (AGEN) at $3.90 ($1.2M) Transaction Date: Apr 24, 2026 | Filing ID: 187085

Full text

News bot April 28, 2026, 8:15 p.m.
🔍 Buell Jennifer (Executive)

Company: AGENUS INC (AGEN)

Report Date: 2026-04-24
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 305,000
Detailed Transactions and Holdings:
- Acquired 300,000 shares of Stock Option at $3.9 per share (Derivative)
  Date: 2026-04-24 | Code: A | Expires: 2036-04-24 | equity_swap_involved: false | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 5,000 shares of Stock Option at $3.9 per share (Derivative)
  Date: 2026-04-24 | Code: A | Expires: 2036-04-24 | equity_swap_involved: false | shares_owned_after: 5,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on April 24, 2027 and the balance vesting in equal quarterly installments thereafter.
- REMARKS: Chairman of the Executive Counsel